231 related articles for article (PubMed ID: 36598340)
21. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
Behl T; Kaur G; Fratila O; Buhas C; Judea-Pusta CT; Negrut N; Bustea C; Bungau S
Transl Neurodegener; 2021 Jan; 10(1):4. PubMed ID: 33446243
[TBL] [Abstract][Full Text] [Related]
22. Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.
Thirumal Kumar D; Eldous HG; Mahgoub ZA; George Priya Doss C; Zayed H
Metab Brain Dis; 2018 Dec; 33(6):1835-1847. PubMed ID: 29978341
[TBL] [Abstract][Full Text] [Related]
23.
Riboldi GM; Di Fonzo AB
Cells; 2019 Apr; 8(4):. PubMed ID: 31010158
[TBL] [Abstract][Full Text] [Related]
24. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
[TBL] [Abstract][Full Text] [Related]
25. Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?
Farfel-Becker T; Do J; Tayebi N; Sidransky E
Trends Neurosci; 2019 Sep; 42(9):631-643. PubMed ID: 31288942
[TBL] [Abstract][Full Text] [Related]
26. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
[TBL] [Abstract][Full Text] [Related]
27. GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
Brody EM; Seo Y; Suh E; Amari N; Hartstone WG; Skrinak RT; Zhang H; Diaz-Ortiz ME; Weintraub D; Tropea TF; Van Deerlin VM; Chen-Plotkin AS
Mov Disord; 2024 Jun; 39(6):1065-1070. PubMed ID: 38610104
[TBL] [Abstract][Full Text] [Related]
28. A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.
den Heijer JM; Cullen VC; Pereira DR; Yavuz Y; de Kam ML; Grievink HW; Moerland M; Leymarie N; Khatri K; Sollomoni I; Spitalny L; Dungeon L; Hilt DC; Justman C; Lansbury P; Groeneveld GJ
Mov Disord; 2023 May; 38(5):783-795. PubMed ID: 36916660
[TBL] [Abstract][Full Text] [Related]
29. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
30. Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
Filippi M; Balestrino R; Basaia S; Agosta F
Mov Disord; 2022 Jul; 37(7):1375-1393. PubMed ID: 35521899
[TBL] [Abstract][Full Text] [Related]
31. A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene.
Lubomski M; Hayes M; Kennerson M; Ellis M; Chu S; Blackie J; O'Sullivan JD; Nicholson G
Mov Disord; 2018 Oct; 33(10):1662-1664. PubMed ID: 30216542
[No Abstract] [Full Text] [Related]
32. GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
Greuel A; Trezzi JP; Glaab E; Ruppert MC; Maier F; Jäger C; Hodak Z; Lohmann K; Ma Y; Eidelberg D; Timmermann L; Hiller K; Tittgemeyer M; Drzezga A; Diederich N; Eggers C
Mov Disord; 2020 Dec; 35(12):2201-2210. PubMed ID: 32853481
[TBL] [Abstract][Full Text] [Related]
33. A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.
Thaler A; Gurevich T; Bar Shira A; Gana Weisz M; Ash E; Shiner T; Orr-Urtreger A; Giladi N; Mirelman A
Parkinsonism Relat Disord; 2017 Mar; 36():47-51. PubMed ID: 28012950
[TBL] [Abstract][Full Text] [Related]
34. The Effect of p.G2019S Mutation in the
Usenko TS; Timofeeva A; Beletskaia M; Basharova K; Baydakova G; Bezrukova A; Grunina M; Emelyanov A; Miliukhina I; Zakharova E; Pchelina S
J Integr Neurosci; 2024 Jan; 23(1):16. PubMed ID: 38287861
[TBL] [Abstract][Full Text] [Related]
35. Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
Dinur T; Bauer P; Beetz C; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Istaiti M; Rolfs A; Zimran A; Revel-Vilk S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163551
[TBL] [Abstract][Full Text] [Related]
36. Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
Liu G; Boot B; Locascio JJ; Jansen IE; Winder-Rhodes S; Eberly S; Elbaz A; Brice A; Ravina B; van Hilten JJ; Cormier-Dequaire F; Corvol JC; Barker RA; Heutink P; Marinus J; Williams-Gray CH; Scherzer CR;
Ann Neurol; 2016 Nov; 80(5):674-685. PubMed ID: 27717005
[TBL] [Abstract][Full Text] [Related]
37. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.
Keatinge M; Bui H; Menke A; Chen YC; Sokol AM; Bai Q; Ellett F; Da Costa M; Burke D; Gegg M; Trollope L; Payne T; McTighe A; Mortiboys H; de Jager S; Nuthall H; Kuo MS; Fleming A; Schapira AH; Renshaw SA; Highley JR; Chacinska A; Panula P; Burton EA; O'Neill MJ; Bandmann O
Hum Mol Genet; 2015 Dec; 24(23):6640-52. PubMed ID: 26376862
[TBL] [Abstract][Full Text] [Related]
38. Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.
Kopytova AE; Rychkov GN; Cheblokov AA; Grigor'eva EV; Nikolaev MA; Yarkova ES; Sorogina DA; Ibatullin FM; Baydakova GV; Izyumchenko AD; Bogdanova DA; Boitsov VM; Rybakov AV; Miliukhina IV; Bezrukikh VA; Salogub GN; Zakharova EY; Pchelina SN; Emelyanov AK
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240451
[TBL] [Abstract][Full Text] [Related]
39. Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
Ran C; Brodin L; Forsgren L; Westerlund M; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Söderkvist P; Puschmann A; Ygland E; Olson L; Willows T; Johansson A; Sydow O; Wirdefeldt K; Galter D; Svenningsson P; Belin AC
Neurobiol Aging; 2016 Sep; 45():212.e5-212.e11. PubMed ID: 27255555
[TBL] [Abstract][Full Text] [Related]
40. The significance of GBA for Parkinson's disease.
Brockmann K; Berg D
J Inherit Metab Dis; 2014 Jul; 37(4):643-8. PubMed ID: 24894157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
